From: Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
Ā | Odds ratio (95% CI) | |
---|---|---|
Ā | AKI during RT | Hospitalizations |
High comorbidity index | 2.74 (1.25ā5.99) | 2.08 (1.05ā4.21) |
P value | .01 | .03 |
Every-3-weeks chemotherapy | 24.38 (3.00ā198.03) | 1.16 (0.41ā3.26) |
P value | .003 | .20 |
Post-operative RT | 0.60 (0.29ā1.24) | 0.66 (0.34ā1.25) |
P value | .17 | .20 |
Cisplatin | 6.38 (0.78ā52.31) | 1.94 (0.67ā5.78) |
P value | .08 | .22 |
Ageāā„ā60 | 0.59 (0.29ā1.22) | 1.64 (0.85ā3.23) |
P value | .60 | .14 |